JP2024521709A5 - - Google Patents

Info

Publication number
JP2024521709A5
JP2024521709A5 JP2023571818A JP2023571818A JP2024521709A5 JP 2024521709 A5 JP2024521709 A5 JP 2024521709A5 JP 2023571818 A JP2023571818 A JP 2023571818A JP 2023571818 A JP2023571818 A JP 2023571818A JP 2024521709 A5 JP2024521709 A5 JP 2024521709A5
Authority
JP
Japan
Application number
JP2023571818A
Other languages
Japanese (ja)
Other versions
JP2024521709A (ja
JPWO2022246039A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/029992 external-priority patent/WO2022246039A1/en
Publication of JP2024521709A publication Critical patent/JP2024521709A/ja
Publication of JP2024521709A5 publication Critical patent/JP2024521709A5/ja
Publication of JPWO2022246039A5 publication Critical patent/JPWO2022246039A5/ja
Pending legal-status Critical Current

Links

JP2023571818A 2021-05-20 2022-05-19 ミトコンドリア関連障害の治療方法 Pending JP2024521709A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163191321P 2021-05-20 2021-05-20
US63/191,321 2021-05-20
US202163222841P 2021-07-16 2021-07-16
US63/222,841 2021-07-16
US202263307515P 2022-02-07 2022-02-07
US63/307,515 2022-02-07
PCT/US2022/029992 WO2022246039A1 (en) 2021-05-20 2022-05-19 Methods of treating mitochondria-related disorders

Publications (3)

Publication Number Publication Date
JP2024521709A JP2024521709A (ja) 2024-06-04
JP2024521709A5 true JP2024521709A5 (https=) 2025-05-27
JPWO2022246039A5 JPWO2022246039A5 (https=) 2025-05-27

Family

ID=82020295

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571818A Pending JP2024521709A (ja) 2021-05-20 2022-05-19 ミトコンドリア関連障害の治療方法

Country Status (14)

Country Link
US (1) US20250177353A1 (https=)
EP (1) EP4340829A1 (https=)
JP (1) JP2024521709A (https=)
KR (1) KR20240021827A (https=)
AU (1) AU2022275935A1 (https=)
BR (1) BR112023024146A2 (https=)
CA (1) CA3219548A1 (https=)
CL (1) CL2023003441A1 (https=)
GE (1) GEAP202416398A (https=)
IL (1) IL308669A (https=)
JO (1) JOP20230298A1 (https=)
MX (1) MX2023013688A (https=)
TW (1) TW202313010A (https=)
WO (1) WO2022246039A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150759A1 (en) * 2022-02-07 2023-08-10 Rivus Pharmaceuticals, Inc. Methods of weight loss in a subject with elevated hba1c
TW202515545A (zh) * 2023-08-10 2025-04-16 大陸商深圳君聖泰生物技術有限公司 2,4-二硝苯酚之衍生物以及前藥、以及其組成物以及方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1098641B1 (en) 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo

Similar Documents

Publication Publication Date Title
CL2025003826A1 (es) Método y sistema para el análisis de datos de monitorización de redes de distribución eléctrica
JP2024521709A5 (https=)
JP2025505632A5 (https=)
CL2025003878A1 (es) Sistemas de generación de energía a partir de fuentes geotérmicas y métodos de operación y construcción de los mismos.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307044877S (https=)
BY13164U (https=)
BY23963C1 (https=)
CN307044291S (https=)
BY13176U (https=)
CN307044339S (https=)
BY13175U (https=)
BY13174U (https=)
BY13160U (https=)